Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer
{{output}}
The identification of mutations in the epidermal growth factor receptor (EGFR) gene has revolutionized the treatment strategy for non-small cell lung cancer (NSCLC). The effectiveness of individualized treatment using EGFR tyrosine kinase inhibitors (TKIs) for... ...
